You are here:

granisetron (Sancuso)

Advice

Following an abbreviated submission:

granisetron 3.1mg / 24 hours transdermal patch (Sancuso®) is accepted for use within NHS Scotland.

Indication under review: in adults for the prevention of nausea and vomiting associated with moderately or highly emetogenic chemotherapy, for a planned duration of 3 to 5 consecutive days, where oral anti-emetic administration is complicated by factors making swallowing difficult.

Granisetron 3.1mg / 24 hours transdermal patch is slightly more expensive than the oral formulation. It provides an alternative option in patients who have difficulty swallowing oral medication.

Drug Details

Drug Name: granisetron (Sancuso)
SMC Drug ID: 895/13
Manufacturer: ProStrakan
Indication: Indicated in adults for the prevention of nausea and vomiting associated with moderately or highly emetogenic chemotherapy, for a planned duration of 3 to 5 consecutive days, where oral anti-emetic administration is complicated by factors making swallowing difficult.
BNF Category:
Sub Category: 4.6 Drugs used in nausea and vertigo
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 7 October 2013

Back